Dendreon Corporation Stock price Nasdaq
Equities
US24823Q1076
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Feb. 20 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
Feb. 12 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
1st Jan change | Capi. | |
---|---|---|
+9.16% | 45.97B | |
+53.63% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Dendreon Corporation
- Stock Dendreon Corporation - Nasdaq